Related Experiment Video
Updated: Aug 13, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Immunological treatment of liver tumors
Maurizio Chiriva-Internati1, Fabio Grizzi, Cynthia A Jumper
1Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, Lubbock, TX 79430-6591, USA. maurizio.chirivainternati@ttushc.edu
Abstract:
Although multiple options for the treatment of liver tumors have often been described in the past, including liver resection, radiofrequency ablation with or without hepatic pump insertion, laparoscopic liver resection and the use of chemotherapy, the potential of immunotherapy and gene manipulation is still largely unexplored. Immunological therapy by gene manipulation is based on the interaction between virus-based gene delivery systems and dendritic cells. Using viruses as vectors, it is possible to transduce dendritic cells with genes encoding tumor-associated antigens, thus inducing strong humoral and cellular immunity against the antigens themselves. Both chemotherapy and radiation therapy have the disadvantage of destroying healthy cells, thus causing severe side-effects. We need more precisely targeted therapies capable of killing cancer cells while sparing healthy cells. Our goal is to establish a new treatment for solid liver tumors based on the concept of cytoreduction, and propose an innovative algorithm.
Insights
This study explores novel immunotherapy and gene manipulation for liver tumors, aiming to precisely target cancer cells while sparing healthy tissue. This approach utilizes virus-based gene delivery to enhance immune responses against tumors.
Area of Science:
- Oncology
- Immunology
- Gene Therapy
Background:
- Current liver tumor treatments like resection, ablation, and chemotherapy have limitations, including side effects.
- The potential of immunotherapy and gene manipulation for liver tumors remains largely unexplored.
- Existing therapies often damage healthy cells alongside cancerous ones.
Purpose of the Study:
- To explore immunotherapy and gene manipulation as a novel treatment for solid liver tumors.
- To propose an innovative algorithm for liver tumor treatment based on cytoreduction.
- To develop targeted therapies that minimize damage to healthy cells.
Main Methods:
- Utilizing virus-based gene delivery systems to transduce dendritic cells.
- Engineering dendritic cells to express tumor-associated antigens.
- Inducing humoral and cellular immunity against tumor antigens.
Main Results:
- The proposed method aims to induce strong immune responses against tumor-associated antigens.
- This approach offers a more targeted strategy compared to traditional chemotherapy and radiation.
- The goal is to achieve tumor cell destruction while preserving healthy liver tissue.
Conclusions:
- Immunotherapy combined with gene manipulation presents a promising avenue for liver tumor treatment.
- This strategy offers a targeted approach to cancer therapy, minimizing collateral damage.
- Further research into this innovative algorithm could lead to improved patient outcomes.
